Mallinckrodt Plc (MNKT): MNK: And a GODZILLA-CLASS monster CONGRA...

MNK: And a GODZILLA-CLASS monster CONGRATS to all

Invest-in-America · 2023-05-19T19:54:16.1630000Z

MNK: And a GODZILLA-CLASS monster CONGRATS to all here who scored GLORIOUS profits today --- just like ME did!!!!! https://media.giphy.com/media/l0MYuiI6EHrZcF8fC/giphy.gif

Play Episode

7min

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Proactive - Interviews for investors

West Cobar Metals' high-grade copper discovery: Bulla Park delivers exceptional results

West Cobar Metals Ltd (ASX:WC1) managing director Matt Szwedzicki talked with Proactive's Jonathan Jackson about the company’s latest metallurgical results from the Bulla Park project. Early-stage testing has delivered high-grade copper, silver, and antimony concentrates with strong recoveries. Szwedzicki described the initial float test results as amazing. A key challenge at Bulla Park has been the presence of tetrahedrite, a less common mineral in Australia. However, recent testing has demonstrated successful separation and recovery processes. The company has now achieved 88% extraction of antimony, a commodity that has surged in value due to reduced exports from China. Szwedzicki also discussed West Cobar’s broader strategy, including plans to optimise metallurgical processes, assess a mineral resource estimate, and advance drilling at Bulla Park. Beyond this, the company is progressing its Salazar project in Western Australia, which holds rare earths, scandium, and alumina resources. The recent acquisition of the Mystique Gold Project further strengthens West Cobar’s portfolio, adding a promising gold exploration target. Stay tuned for more updates from West Cobar Metals. If you enjoyed this interview, give the video a like, subscribe to Proactive’s YouTube channel, and turn on notifications for the latest mining insights. #WestCobarMetals #Copper #Antimony #Mining #ASX #BullaPark #RareEarths #GoldExploration #Metals #Investing #Resources

Proactive - Interviews for investors

Major investment: AuKing’s $5M earn-in deal

AuKing Mining Ltd managing director Paul Williams joins Proactive’s Jonathan Jackson to discuss the company’s right to earn up to a 50% stake in Orion Resources Pty Ltd, which is acquiring the Cloncurry Gold Project in northwest Queensland. The agreement extends a prior deal allowing AuKing to earn a 15% stake through $1.5 million in project-related expenditure. Under the new terms, AuKing must invest $5 million in project development by June 30, 2027. Orion is finalising the acquisition of the Cloncurry Gold Project, the Lorena processing plant, and the Mt Freda/Golden Mile deposits. The company is also considering processing material from the Tick Hill mine and tailings. AuKing’s investment will support exploration, drilling, and resource estimation work, particularly at Mt Freda/Golden Mile, as well as refurbishment of the Lorena plant. Upon completing the $5 million earn-in, AuKing and Orion will form an incorporated joint venture, with AuKing holding a 50% share. If AuKing does not meet the expenditure requirement, its interest will lapse. Orion will fund the purchase of the Cloncurry Gold Project independently, and AuKing has no further automatic acquisition rights beyond the 50% stake. ➡️ Watch the full interview for more insights! 🔔 Don’t forget to like, subscribe, and turn on notifications for more updates from Proactive. #AuKingMining #GoldMining #MiningStocks #CloncurryGold #OrionResources #Investing #ASX #GoldExploration #MiningUpdates #GoldProduction

Proactive - Interviews for investors

Empire Metals MD on high-purity titanium breakthrough

Empire Metals Ltd (AIM:EEE) managing director Shaun Bunn talked with Proactive about the company's latest metallurgical test results at the Pitfield project. The test work delivered an impressive 91.6% purity titanium dioxide compound—achieved on the first attempt. Bunn emphasised that this high-grade product is free from deleterious contaminants, making it suitable for further processing into titanium sponge metal or premium-grade titanium pigments. He explained that the team successfully extracted and refined the titanium-bearing minerals using gravity separation, flotation, and acid digestion techniques. The company is now focused on optimising its processing flow sheet and scaling up test work. Recent bulk metallurgical sample collections at Pitfield will support larger-scale testing, with the goal of producing more of this high-grade product for market analysis. Bunn also highlighted that the simplicity of Pitfield's mineral composition, free from heavy metals or radioactive elements, has contributed to the rapid progress in refining processes. With further purification testing ahead, Empire Metals is poised to advance its titanium strategy. For more insights from this interview, visit Proactive’s YouTube channel. Don't forget to like, subscribe, and turn on notifications for future updates. #EmpireMetals #Titanium #Mining #PitfieldProject #Metallurgy #TitaniumDioxide #MineralProcessing #MiningStocks #TitaniumSponge #Investing

Followers	221
Posts	13482
Boards Moderated	10
Alias Born	06/20/2022

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Join the InvestorsHub Community

Go Ad-Free